Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2016 Earnings

7NovConfirmed

Q1 2016

Q2 2016

Q3 2016

Q4 2016

-0.63

-0.55

-0.46

-0.38

Details

Expected EPS

-0.58

Actual EPS

-0.61

Surprise EPS

-0.03

Surprise Percent

+5.17%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.61 per share for Q4 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.